An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

About a third of older men with lower urinary tract symptoms obtained minimal benefit from tamsulosin and might be candidates for deprescribing. Only four patients in this study obtained substantial ...

Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a ...

Phase 2b Elumina trial; topline data anticipated in Q4 2026 (ClinicalTrials.gov: NCT06524830) AtaiBeckley plans to advance VLS-01 into major depressive disorder (MDD) in Phase 3, with generalized ...

A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx) are ...

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

Environmental sustainability in tertiary sports remains an emergent yet under-resourced domain, particularly in sub-Saharan ...

The transmission of optical information through random scattering media is a major challenge in optics, biomedical imaging, ...

ATAI completes dosing in the phase IIb Elumina study of VLS-01 for treatment-resistant depression, with top-line efficacy and ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...